Atlas Capital Advisors LLC Galapagos Nv Transaction History

Atlas Capital Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$42.27 - $57.6 $14,709 - $20,044	348 New	348 $14.8 Million
Q2 2022 Aug 16, 2022	SELL	$52.3 - $71.59 $18,200 - $24,913	-348 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$47.03 - $57.12 $32,921 - $39,984	-700 Reduced 66.79%	348 $19.2 Million
Q2 2021 Jul 30, 2021	BUY	$68.86 - $83.34 $48,202 - $58,338	700 Added 201.15%	1,048 $72,000
Q1 2021 May 10, 2021	SELL	$76.15 - $111.94 $40,587 - $59,664	-533 Reduced 60.5%	348 $26,000
Q4 2020 Feb 16, 2021	BUY	$96.85 - $148.25 $85,324 - $130,608	881 New	881 $87,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Atlas Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Atlas Capital Advisors LLC with notifications on news.